Table 2 Disease and medication characteristics of the study participants (n = 427)
Variables | n (%) | Mean (SD a) |
|---|---|---|
Disease related | Â | Â |
Duration of heart failure (years) |  | 6.41 (± 6.16) |
Number of other chronic diseases |  | 3 (± 1) |
NYHA b classification | Â | Â |
I/II | 130 (30.4) | Â |
III/IV | 298 (69.6) | Â |
Type of comorbidities | Â | Â |
Hypertension | 330 (77.1) | Â |
Diabetes Mellitus | 262 (61.2) | Â |
Ischemic Heart Diseases | 275 (64.3) | Â |
Dyslipidemia | 142 (33.2) | Â |
Chronic Kidney Disease | 56 (13.1) | Â |
Thyroid Dysfunction | 36 (8.4) | Â |
Heart failure medications | Â | Â |
Aldosterone Antagonist | 81 (18.9) | Â |
Digoxin | 46 (10.7) | Â |
ACEIs c/ARBs d | 286 (66.8) | Â |
Beta blocker | 379 (88.6) | Â |
Loop diuretic | 289 (67.5) | Â |
Vasodilator | 79 (18.5) | Â |
Calcium Channel Blocker | 81 (18.9) | Â |
Ivabradine | 20 (4.7) | Â |
Valsartan/ Sacubitril | 31 (7.2) | Â |
Other medications | Â | Â |
Anticoagulant | 148 (34.6) | Â |
Statin | 303 (70.8) | Â |
Number of Medications |  | 8 (± 3) |
Number of heart failure medications |  | 3 (± 1) |
Medications frequency | Â | Â |
Once | 78 (18.2) | Â |
Twice | 249 (58.2) | Â |
Thrice or more | 101 (23.6) | Â |
Fear of medications’ side effects |  |  |
No | 305 (71.3) | Â |
Yes | 123 (28.7) | Â |
Medications satisfaction | Â | Â |
No | 97 (22.7) | Â |
Yes | 331 (77.3) | Â |
Experiencing side effects | Â | Â |
No | 291 (68) | Â |
Yes | 137 (32) | Â |